...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2023 Anastomosis Bladder cancer Radical cystectomy Outcomes The gold standard in patients with muscle-invasive...

.... 2023 Bladder cancer Urothelial carcinoma Cytology Transurethral resection of the bladder Sensitivity Diagnostic test Accurate histopathologic staging and grading are crucial in disease management of urothelial carcinoma of the bladder (BCa) as it may present as an aggressive disease...

... Bladder cancer Complexity Transurethral resection of bladder tumours Complications Checklist Bladder cancer (BC) is the second most prevalent tumour of the genitourinary tract [ 1 ] and is characterised by a high probability of recurrence and progression [ 2 ]. Transurethral resection...

...Deniz Bolat; Sumer Baltaci; Murat Akgul; Emre Karabay; Volkan Izol; Guven Aslan; Saadettin Eskicorapci; Hayrettin Sahin; Levent Turkeri; Members of Bladder Cancer Study Group of Turkish Urooncology Association Introduction: In this study, we aimed to explore using the predictive role of systemic...

...Yang Fu; Kun Liu; Xi Jiang; Lun Zhao; Tianwei Wang Introduction: Circular RNAs (circRNAs) are related to the pathogenesis and progression of bladder cancer (BC). This research aimed to investigate the role and mechanism of hsa_circ_0008035 (circ_0008035) in BC progression. Methods: Circ_0008035...

... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2022 Bladder cancer Radical...

... to in the content or advertisements. 2022 Bladder cancer Mortality Epidemiology Complications Urinary diversions Radical cystectomy Radical cystectomy (RC) is currently considered as the standard of care for patients with muscle-invasive bladder cancer (MIBC) without systemic involvement...

... molecular subtypes of bladder cancer. In this study, we aimed to correlate FOXA1, a marker for differentiation of the basal and luminal subtypes, with tumor immune cell infiltration and the effect of chemotherapy in bladder cancer. Materials and Methods: Eighty-three patients with bladder cancer treated...

...Michele Zazzara; Arjan Nazaraj; Marcello Scarcia; Giuseppe Cardo; Roberto Carando; Giuseppe Mario Ludovico Background: Although TURB of tumor (TURBT) by itself can eradicate a non-muscle-invasive bladder cancer (NMIBC) completely, these tumors commonly recur and can progress to MIBC...

...; Franz F. Dressler; Mario W. Kramer; Johannes Salem Introduction: Guideline recommendations are meant to help minimize morbidity and to improve the care of nonmuscle invasive bladder cancer (NMIBC) patients but studies have suggested an underuse of guideline-recommended care. The aim of this study...

...Zhijiang Zang; Nisha Raishmi Kesavan; Kesavan Esuvaranathan Objectives: Bladder cancer is a common type of malignancy. UBC®Rapid is a novel immunoassay detecting urine cytokeratin 8/18 protein. Studies have shown good accuracy of UBC®Rapid in detecting bladder cancer. UBC®Rapid has however to date...

... stratification. Yet, it remains unclear how age influences their prognostic value. The current study aimed to assess the impact of age on standard prognostic biomarkers in different age-groups. Materials and Methods: Overall, 1,014 patients undergoing RC for bladder cancer were included. Patients were divided...

... UTUCR RFs are non-muscle invasive bladder carcinoma (NMIBC) (OR 3.8, 95% confidence intervals [CI] 1.4–10.2, p = 0.008), multifocal bladder cancer in cystectomy specimen (OR 4.7, CI 1.1–20.8, p = 0.042), and recurrent NMIBC (OR 4.1, CI 1.5–10.9, p = 0.006). Risk-group stratification showed a six-fold...

...Philipp Weinhold; Friedrich Jokisch; Gerald Bastian Schulz; Alexander Buchner; Philipp Maximilian Kazmierczak; Alexander Kretschmer; Boris Schlenker; Alexander Karl; Christian G. Stief; Tobias Grimm Introduction: Palliative radical cystectomy (pRC) may be offered to selected bladder cancer (BC...

...-to-use technique. Bladder cancer (BC) is the 9th most common cancer diagnosed worldwide [1]. Transurethral resection of bladder tumor (TURBT), using a monopolar loop resectoscope, is the standard method of endoscopic resection of nonmuscle-invasive BC [2]. The most common complication...

...Lukas Püllen; Cordelia Kaspar; Andrej Panic; Jochen Hess; Henning Reis; Tibor Szarvas; Jan Philipp Radtke; Ulrich Krafft; Christopher Darr; Boris Hadaschik; Stephan Tschirdewahn Objective: Patients with bladder cancer (BC) are at risk of developing upper tract urothelial carcinoma (UTUC). Therefore...

...Johannes Rückher; Jessica Lobitz; Markus Follmann; Steffi Derenz; Stefanie Schmidt; Jumana Mensah; Simone Wesselmann Introduction: As part of the development of the evidence-based (S3) clinical practice guidelines for kidney and bladder cancer by the German Guideline Program in Oncology, quality...

... of LINC00707 in bladder cancer (BC) was not yet clear. Our researches aimed to determine whether LINC00707 was dysregulated in BC and further study its biological functions. Methods: LINC00707 levels in BC tissues and cells were measured using reverse transcription-PCR (RT-PCR), and the associations between...

..., instructions or products referred to in the content or advertisements. Bladder cancer Pathology Progression Recurrence Survival Substaging system The main prognostic factor of urothelial bladder carcinoma (UBC) is its pathological classification. Whereas superficial (pTa) and invasive (≥pT2...

...Yongsong Liu; Xiande Huang; Lijun Guo; Nengqin Luo Bladder cancer (BC), as one of the most common cancers around the world, begins in the inner side of the bladder and is inclined to spread to the remaining parts of the body. Extensive documents have shown that long noncoding RNAs function...